About this trial
CiGal-EI-TEP is an exploratory study that aim to assess the diagnostic performance of 68Ga Positron emission tomography (PET) / Computed Tomography (CT) for the diagnosis of prosthetic valve infective endocarditis in comparison with the final diagnosis established according to the ESC 2023 criteria, after 3 months of follow-up, by a panel of experts.
Eligibility criteria
Qualifiers
adult patient (over 18 years old);
patient with a prosthetic heart valve;
patient suspected of infective endocarditis (on clinical and/or microbiological and/or imaging data);
patient whose history is discussed in the multidisciplinary meeting dedicated to endocarditis;
Disqualifiers
pregnant or breastfeeding women;
women of childbearing potential not using effective contraception;
patients referred to in articles L.1121-5 to L.1121-8 (persons deprived of liberty by judicial or administrative decision, minors, adults subject to a legal protection measure or unable to express their consent);
subject in a period of relative exclusion due to another protocol;
Trial design
Treatments tested in this trial
- 68Ga-citrate PET/CT